rs551238
This is a regulatory region variant variant in the EPO gene.
▶GWAS Catalog Trait Associations (2)
Genome-wide significant associations (p < 5×10⁻⁸) from the NHGRI-EBI GWAS Catalog.
GWAS Catalog Trait Associations (2)
Genome-wide significant associations (p < 5×10⁻⁸) from the NHGRI-EBI GWAS Catalog.
erythrocyte count
hematocrit
▶Research that mentions this SNP (2)
▶Genetic association analysis highlights new loci that modulate hematological trait variation in Caucasians and African AmericansAssociationN=30,551Ken Sin Lo et al.(2011)· Human Genetics
Genetic association study in 23,439 Caucasians and 7,112 African Americans identified novel loci modulating hematological traits. G6PD rs1050828 (Val68Met) shows strong association with red blood cell count, hemoglobin, hematocrit, and mean corpuscular volume in African Americans (P < 2.0 × 10^−13), while TPM4 rs8109288 associates with platelet count in both Caucasians and African Americans (P = 3.0 × 10^−7). HBA2-HBA1 rs1211375 associates with red blood cell traits specifically in African Americans (P < 7 × 10^−8). Study replicated 36 previously reported associations and highlights ethnic differences in genetic architecture of blood traits.
▶Association Between Erythropoietin Gene Polymorphisms and Diabetic RetinopathyAssociationN=518Abhary S. et al.(2010)· Archives of Ophthalmology
This case-control association study of 518 Australian subjects with diabetes found that three EPO (erythropoietin) gene SNPs (rs1617640, rs507392, rs551238) were significantly associated with diabetic retinopathy risk, particularly in type 2 diabetes. The GCC haplotype showed increased frequency in diabetic retinopathy cases with adjusted p-values of 0.006-0.008, and associations remained significant after adjustment for HbA1c, disease duration, and nephropathy.
About EPO
This gene encodes a secreted, glycosylated cytokine composed of four alpha helical bundles. The encoded protein is mainly synthesized in the kidney, secreted into the blood plasma, and binds to the erythropoietin receptor to promote red blood cell production, or erythropoiesis, in the bone marrow. Expression of this gene is upregulated under hypoxic conditions, in turn leading to increased erythropoiesis and enhanced oxygen-carrying capacity of the blood. Expression of this gene has also been observed in brain and in the eye, and elevated expression levels have been observed in diabetic retinopathy and ocular hypertension. Recombinant forms of the encoded protein exhibit neuroprotective activity against a variety of potential brain injuries, as well as antiapoptotic functions in several tissue types, and have been used in the treatment of anemia and to enhance the efficacy of cancer therapies. [provided by RefSeq, Aug 2017]
View all EPO variants →Gene information from NCBI Gene. Variant classifications from ClinVar.
Community Wiki
No community notes yet for this variant. Sign in to start one.
Comments
Sign in to join the discussion.
Loading comments…